Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zepp Health (ZEPP) EBITDA: 2015-2024

Historic EBITDA for Zepp Health (ZEPP) over the last 10 years, with Dec 2024 value amounting to -$47.2 million.

  • Zepp Health's EBITDA rose 92.95% to -$884,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.3 million, marking a year-over-year increase of 8.99%. This contributed to the annual value of -$47.2 million for FY2024, which is 55.17% down from last year.
  • As of FY2024, Zepp Health's EBITDA stood at -$47.2 million, which was down 55.17% from -$30.4 million recorded in FY2023.
  • Zepp Health's EBITDA's 5-year high stood at $26.7 million during FY2020, with a 5-year trough of -$61.9 million in FY2022.
  • For the 3-year period, Zepp Health's EBITDA averaged around -$46.5 million, with its median value being -$47.2 million (2024).
  • Per our database at Business Quant, Zepp Health's EBITDA crashed by 519.63% in 2022 and then spiked by 50.77% in 2023.
  • Over the past 5 years, Zepp Health's EBITDA (Yearly) stood at $26.7 million in 2020, then crashed by 44.79% to $14.7 million in 2021, then tumbled by 519.63% to -$61.9 million in 2022, then skyrocketed by 50.77% to -$30.4 million in 2023, then crashed by 55.17% to -$47.2 million in 2024.